Certara (CERT)

• Market cap: $2.28B
• 1 day: 4.58%
• 5 days: 19.51%
• 1 month: 28.17%
• 3 months: 21.36%
• 6 months: 22.30%
• Year to date: 32.74%
• 1 year: -16.52%
• 5 years: -62.84%
• 10 years: -62.84%
• Sector: Healthcare
• Industry: Health Information Services

About: Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Employees: 1,546

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

2,163% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $68K

21% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 70

2% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 42

0.41% more ownership

Funds ownership: 71.85% [Q3] → 72.26% (+0.41%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

1% less funds holding

Funds holding: 224 [Q3] → 221 (-3) [Q4]

8% less capital invested

Capital invested by funds: $1.35B [Q3] → $1.24B (-$114M) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $11 22% downside
• Avg. target: $14.75 4% upside
• High target: $18 27% upside

4 analyst ratings

• positive: 2 50%
• neutral: 2 50%
• negative: 0 0%

Keybanc Scott Schoenhaus 38% 1-year accuracy 15 / 39 met price target	27% upside $18	Overweight Maintained	16 Apr 2025
Baird Joe Vruwink 38% 1-year accuracy 16 / 42 met price target	8% downside $13	Neutral Maintained	11 Apr 2025
Barclays Luke Sergott 28% 1-year accuracy 16 / 57 met price target	22% downside $11	Equal-Weight Maintained	10 Apr 2025
Stephens & Co. Jeff Garro 70% 1-year accuracy 7 / 10 met price target	20% upside $17	Overweight Reiterated	27 Feb 2025